These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3381200

  • 1. Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets.
    Hofmann B, Ostermann G, Kertscher HP, Till U.
    Thromb Res; 1988 Feb 15; 49(4):415-23. PubMed ID: 3381200
    [Abstract] [Full Text] [Related]

  • 2. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    J Lipid Mediat; 1990 Feb 15; 2(1):21-31. PubMed ID: 1966804
    [Abstract] [Full Text] [Related]

  • 3. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues.
    Ostermann G, Kertscher HP, Till U.
    Biomed Biochim Acta; 1985 Feb 15; 44(2):K17-23. PubMed ID: 4004829
    [Abstract] [Full Text] [Related]

  • 4. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. II. Relationships between chemical structure and inhibition of PAF-induced human platelet activation.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    J Lipid Mediat; 1991 Feb 15; 3(2):225-37. PubMed ID: 1797154
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of PAF-induced human platelet responses by newly synthesized ether phospholipids.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    Thromb Res; 1991 Feb 01; 61(3):261-9. PubMed ID: 2028445
    [Abstract] [Full Text] [Related]

  • 6. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec 01; 342(6):713-8. PubMed ID: 2096302
    [Abstract] [Full Text] [Related]

  • 7. Effects of synthetic analogues of platelet-activating factor (PAF) on fibrinolytic activity in the rat.
    Hofmann B, Meisgeier U, Kertscher P, Ostermann G.
    Biomed Biochim Acta; 1988 Dec 01; 47(10-11):S161-4. PubMed ID: 3150268
    [Abstract] [Full Text] [Related]

  • 8. Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists.
    Tokumura A, Yoshida J, Okasaka N, Fukuzawa K, Tsukatani H.
    Thromb Res; 1987 Apr 01; 46(1):153-61. PubMed ID: 3590110
    [Abstract] [Full Text] [Related]

  • 9. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
    Grigoriadis G, Stewart AG.
    Br J Pharmacol; 1991 Sep 01; 104(1):171-7. PubMed ID: 1664761
    [Abstract] [Full Text] [Related]

  • 10. The enantiomer and the positional isomer of platelet-activating factor.
    Tence M, Coëffier E, Polonsky J, Benveniste J.
    Biochim Biophys Acta; 1983 Feb 22; 755(3):526-30. PubMed ID: 6824744
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and proaggregatory activity of 1-O-(2-methyloctadecyl)-2-O-acetyl-rac-glycero-3-phosphocholine.
    Schmid B, Ostermann G, Kertscher HP.
    Chem Phys Lipids; 1991 Nov 22; 60(1):77-82. PubMed ID: 1813180
    [Abstract] [Full Text] [Related]

  • 12. Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moiety.
    Takatani M, Yoshioka Y, Tasaka A, Terashita Z, Imura Y, Nishikawa K, Tsushima S.
    J Med Chem; 1989 Jan 22; 32(1):56-64. PubMed ID: 2909744
    [Abstract] [Full Text] [Related]

  • 13. Effect of structural analogues of PAF-acether on platelet desensitization.
    Keraly CL, Coëffier E, Tencé M, Borrel MC, Benveniste J.
    Br J Haematol; 1983 Mar 22; 53(3):513-21. PubMed ID: 6824590
    [Abstract] [Full Text] [Related]

  • 14. Effect of synthetic phospholipids on platelet aggregation and serotonin release.
    Söling U, Eibl H, Nagel GA, Unger C.
    Lipids; 1987 Nov 22; 22(11):868-70. PubMed ID: 3444380
    [Abstract] [Full Text] [Related]

  • 15. [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group].
    Kertscher HP, Ostermann G.
    Pharmazie; 1987 Nov 22; 42(11):713-5. PubMed ID: 3438334
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activation of human and rabbit blood platelets by synthetic structural analogs of platelet activating factor.
    Hadváry P, Baumgartner HR.
    Thromb Res; 1983 Apr 15; 30(2):143-56. PubMed ID: 6868019
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs.
    Coëffier E, Borrel MC, Lefort J, Chignard M, Broquet C, Heymans F, Godfroid JJ, Vargaftig BB.
    Eur J Pharmacol; 1986 Nov 19; 131(2-3):179-88. PubMed ID: 3816952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.